Black Diamond Relocates Research Group to Alexandria Center
Black Diamond Therapeutics, a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, has inked an 18,120-square-foot office lease for its research group at 430 E. 29th St., the Alexandria Center for Life Science. The tenant currently has office space at 180 Varick St.
The CBRE Life Sciences team of Joseph DeRosa and John Isaacs represented Black Diamond in negotiations with landlord Alexandria Real Estate Equities. September occupancy is expected.
“Life sciences companies continue to experience growth in the New York City market, most of which is fueled by a significant uptick in venture capital funding flowing into this space, but it is also comprised of mid-sized groups that are further along in their life cycle,” said Isaacs. “Black Diamond required permanent space for its research group and identified the Alexandria Center for Life Science as the ideal facility for the company’s next stage.”